IONIS PHARMACEUTICALS INC earnings per share and revenue

ISI earnings per share for the last quarter are -0.88 CHF whereas the estimation was -0.93 CHF which accounts for 5.12% surprise. Company revenue for the same period amounts to 107.35 M CHF despite the estimated figure of 118.56 M CHF. Estimated earnings per share for the next quarter are -0.86 CHF, and revenue is expected to reach 132.48 M CHF. Also watch annual changes over time to get a bigger picture of ISI earnings per share and revenue dynamics.